Keagan Lenihan is the Associate Commissioner for Strategic Initiatives and External Affairs within the Office of the Commissioner at the U.S Food and Drug Administration (FDA). In her current role, Mrs. Lenihan is focused on priority projects across the agency, Department of Health and Human Services (HHS), Executive Offices of the President (EOP) and entire U.S. Government. In this role, she leads and advances our work in opioids, drug shortages and other strategic initiatives as well as advance the FDA’s communication portfolio through stakeholder engagement and assisting with collaborations with Federal partners. She also oversees media affairs, internal communications, FDA Voices, the agency’s website and the work underway to enhance our web presence.
Immediately prior, Mrs. Lenihan served as the Senior Counselor to the Secretary of HHS where she focused on drug pricing reform initiatives, reduction in patient and provider regulatory burden, price transparency and patient empowerment, The Office of Health Reform, and assisting with the Center for Medicare and Medicaid Services (CMS) portfolio. Prior to entering the Administration, Mrs. Lenihan was in the private sector for five years as an executive with McKesson Specialty Health managing federal government relations. She spent nearly a decade on Capitol Hill working for three Members of Congress in key leadership positions as well as the House Rules Committee staff. Mrs. Lenihan received her degree from the University of Colorado, Boulder; and resides with her family in Virginia.